T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Manhattan Associates
MANH
$11.7B
| $124M | 0.01% |
439,747
+51,166
| +13% | +$13M |
|
527
United Therapeutics
UTHR
$21.5B
| $123M | 0.01% |
344,527
+109,611
| +47% | +$37M |
|
528
Sprouts Farmers Market
SFM
$7.71B
| $120M | 0.01% |
1,088,091
-237
| -0% | -$22.6K |
|
529
Summit Therapeutics
SMMT
$11.2B
| $119M | 0.01% |
5,439,657
+3,397,557
| +166% | +$47.5M |
|
530
Kilroy Realty
KRC
$4.3B
| $119M | 0.01% |
3,072,096
-245,568
| -7% | -$8.68M |
|
|
CFLT
531
DELISTED
Confluent
CFLT
| $119M | 0.01% |
5,829,069
-11,124,418
| -66% | -$249M |
|
532
NiSource
NI
$20.2B
| $118M | 0.01% |
3,413,585
-2,991,393
| -47% | -$95.5M |
|
|
SRCL
533
DELISTED
Stericycle Inc
SRCL
| $118M | 0.01% |
1,933,403
-38,112
| -2% | -$2.26M |
|
534
Onto Innovation
ONTO
$20.6B
| $117M | 0.01% |
564,012
-188,938
| -25% | -$38.1M |
|
535
Truist Financial
TFC
$64.7B
| $117M | 0.01% |
2,727,305
-361,422
| -12% | -$15.3M |
|
536
Murphy USA
MUSA
$10.4B
| $116M | 0.01% |
235,672
-10,461
| -4% | -$5.25M |
|
537
The Ensign Group
ENSG
$10.6B
| $115M | 0.01% |
801,617
-42,268
| -5% | -$6.02M |
|
|
AXON
538
Axon Enterprise
AXON
$50B
| $115M | 0.01% |
286,943
+14,955
| +5% | +$5.16M |
|
539
Oscar Health
OSCR
$9.5B
| $114M | 0.01% |
5,388,061
+431,626
| +9% | +$7.77M |
|
540
Capital One
COF
$137B
| $114M | 0.01% |
762,643
-52,770
| -6% | -$7.51M |
|
541
Liberty Media Series C
FWONK
$26B
| $113M | 0.01% |
1,457,907
+242,478
| +20% | +$18.7M |
|
|
SWTX
542
DELISTED
SpringWorks Therapeutics
SWTX
| $113M | 0.01% |
3,516,418
-85,816
| -2% | -$3.21M |
|
543
Zegna
ZGN
$3.73B
| $113M | 0.01% |
11,446,653
-1,556,805
| -12% | -$16.1M |
|
544
Monster Beverage
MNST
$91.4B
| $112M | 0.01% |
4,291,002
-86,516
| -2% | -$2.14M |
|
|
NUVL
545
DELISTED
Nuvalent
NUVL
| $111M | 0.01% |
1,082,277
+328,139
| +44% | +$27.2M |
|
546
Wynn Resorts
WYNN
$10.5B
| $110M | 0.01% |
1,150,859
+155,113
| +16% | +$12.5M |
|
547
Fastenal
FAST
$58.9B
| $110M | 0.01% |
3,068,602
+84,924
| +3% | +$2.87M |
|
548
Ecolab
ECL
$77.4B
| $109M | 0.01% |
428,344
-346
| -0.1% | -$84.6K |
|
|
AKRO
549
DELISTED
Akero Therapeutics
AKRO
| $109M | 0.01% |
3,808,359
-337,992
| -8% | -$8.81M |
|
550
Nutanix
NTNX
$18.4B
| $109M | 0.01% |
1,837,828
-441,743
| -19% | -$24.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.